Navigation Links
MEDIHONEY(TM) Dressings Shown to Help Improve Outcomes of Non-Healing Venous Leg Ulcers in Recent Case Series
Date:2/13/2009

ital, these patients' quality of life can be improved tremendously if their wounds healed more quickly."

According to the authors (Tanisha Smith, DPM and Kennedy Legel, DPM of South Miami Hospital, and Jason R. Hanft, DPM, Director of Medical Education, Baptist Health South Florida), "As renewed interest in the use of sterile, medical-grade honey to achieve wound closure increases, justified by increased scientific and clinical data, the healing potential of Medihoney may serve as a pivotal clinical decision to accelerate the closure of recalcitrant wounds of the lower extremity."

The data from this case series has also been submitted and accepted for presentation at two of the major wound conferences in 2009: The Diabetic Foot Global Conference (DFCon) in Los Angeles, March 19-21, and The Wound Healing Society Annual Conference (WHS) in Dallas, April 26-29.

About venous leg ulcers

  • Venous leg ulcers are difficult to heal, and impair the quality of life of patients due to pain, reduction in daily living capabilities, and issues with odor (1)
  • Roughly 1% of the population will have a venous leg ulcer at some point in their lifetime (2)
  • The costs to treat venous leg ulcers in the US exceeds $1 billion (3)

    (1) Charles H. Venous leg ulcer pain and its characteristics. Journal of
        Tissue Viability. 2002;12(4):154-158.
    (2) Margolis D, Bilker W, Santanna J, Baumgarten M. Venous leg ulcer:
        incidence and prevalence in the elderly. J Am Acad Dermatol.
        2002;46(3):381-386.
    (3) de Araujo et al., Ann. Intern. Med. 2003;138(4):326-34.

About Derma Sciences

Derma Sciences is a global manufacturer and marketer of advanced wound-care products. Its key product, MEDIHONEY(TM), is sold throughout the world by Derma Sciences and Comvita New Zealand -- the
'/>"/>

SOURCE Derma Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Derma Sciences MEDIHONEY(TM) Proven to Speed Healing in Stalled Leg Ulcers
2. Randomized Controlled Clinical Trial Shows Derma Sciences MEDIHONEY(TM) Eradicates MRSA From Chronic Venous Ulcers
3. Cardiovascular Researchers Use MEDIHONEY(TM) on Sternal Infections Following Open-Heart Procedures
4. Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study
5. SELECT TRIAL Used Selenomethionine Instead of High-Selenium Yeast, SelenoExcell(R) - Previous Research has Shown SelenoExcell(R) Supplementation to Reduce Lung, Colon and Prostate Cancers by as Much as 63%, Says Cypress Systems, Inc.
6. Protein Shown to Play a Key Role in Normal Development of Nervous System
7. Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months
8. CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date
9. Evotecs EVT 101 Shown to Penetrate the Brain in Man and to Modulate Brain Activity During the Performance of Cognitive Tasks
10. Divine Corporations Personal Lubricants Shown to Block Cancer-causing Viruses in a Study by the National Cancer Institute
11. SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... , Sept. 4, 2015  PTC Therapeutics, Inc. ... five recipients of its first-ever global awards program, ... and Empowerment), designed to aid nonprofit organizations that ... (DMD) community. The announcement is made as the ... Duchenne Awareness Day on Monday, September 7, 2015. ...
(Date:9/4/2015)... , Sept. 4, 2015  IGI Laboratories, Inc. ... based specialty generic pharmaceutical company, today announced it ... to the U.S. Food and Drug Administration (FDA) of ... submissions now pending at the FDA to twenty-nine. ... the Company, commented, "We believe our current pipeline of ...
(Date:9/4/2015)... , Sep. 04, 2015 ... http://www.researchandmarkets.com/research/dvzsqg/investigation ) has announced the addition of ... Hyaluronate Market, 2010-2019" report to their ... long-chain polymer containing repeating disaccharide units of ... fluid and cartilage matrix, sodium hyaluronate can ...
Breaking Medicine Technology:PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 2PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 3PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 4IGI Laboratories, Inc. Announces Seventh ANDA Submission Of 2015 2Investigation Report on China's Sodium Hyaluronate Market 2015 2
... - Peregrine's Selective Anti-VEGF Antibodies Inhibited Tumor Growth By, ... 90% In ... Inhibit VEGF Receptor,2 Could , Potentially Have Advantages over Non-Selective Approaches ... Fully Human,Antibody Support , Advancing Peregrine's Anti-VEGF Program towards Clinical Trials,- ...
... AACR Annual Meeting, BLOOMFIELD, N.J., April 16, 2007 ... and in vitro,preclinical data presented in a poster ... Meeting show that ONCONASE,(ranpirnase) significantly inhibits tumor growth ... cells. , In the poster titled "Increased apoptosis ...
Cached Medicine Technology:Data Presented at AACR Meeting Shows Peregrine's Selective,Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical,Cancer Models 2Data Presented at AACR Meeting Shows Peregrine's Selective,Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical,Cancer Models 3Data Presented at AACR Meeting Shows Peregrine's Selective,Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical,Cancer Models 4Data Presented at AACR Meeting Shows Peregrine's Selective,Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical,Cancer Models 5Preclinical Data Show Alfacell's Onconase Inhibits Tumor Growth of,Non-Small Cell Lung Cancer, Breast Cancer Cells 2Preclinical Data Show Alfacell's Onconase Inhibits Tumor Growth of,Non-Small Cell Lung Cancer, Breast Cancer Cells 3
(Date:9/4/2015)... ... September 04, 2015 , ... With TransCel from Pixel ... all within Final Cut Pro X. With TransCel users have full control over camera ... background color, speed method, frame color, inner color, text, and more. With TransCel the ...
(Date:9/4/2015)... ... September 04, 2015 , ... The Schmidt National Law Group filed an Essure® ... , Schmidt National Law Group, a leading firm in mass-tort litigation, has filed a ... Bayer Essure, Inc., and other Bayer affiliates for injuries alleged to have been caused ...
(Date:9/4/2015)... , ... September 04, 2015 , ... IVF New England, ... a New Hampshire fertility "ManchVegas Happy Hour" in Manchester for women who wish to ... 2015 at XO on Elm restaurant and lounge, 827 Elm Street, Manchester, NH from ...
(Date:9/4/2015)... ... 04, 2015 , ... After wearing the same uniforms for six seasons, the ... an effort to assist the team, the Jones Agency, a locally owned insurance firm ... funds for the new uniforms. , As is so often the case with high ...
(Date:9/4/2015)... ... September 04, 2015 , ... A Union County ... Core Compassion Project is a non-profit organization dedicated to offering Pilates scholarships ... of cancer treatments and recover their mobility, strength, and range of motion following ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Releases TransCel, a New FCPX Transition 2Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:IVF New England to Host ManchVegas New Hampshire Fertility Happy Hour on October 15, 2015 in Manchester for Women Who Wish to Learn More About Fertility and Egg Freezing 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 3Health News:Girl’s Night Out to Benefit Core Compassion Project, Located at the Beautiful, Morning Glory Farm 2
... , , NEW YORK, ... report is available in its catalogue. , , ... Sera and Reagents, 2nd Edition , , ... Cell culture is a major foundation of biopharmaceutical development, bioprocessing ...
... ... FaxBack,s HTTPS-Based VoIP Fax With the Convenience of FaxSIPit,s Services-based Model , ... Tigard, OR and Vancouver, BC, ... server solutions for business, enterprise and carrier applications, and FaxSIPit , a leading ...
... health advocates say, , TUESDAY, Sept. 22 (HealthDay News) -- ... chocolate when they light up are about to have their ... and candy-flavored cigarettes takes effect Sept. 22. , The prohibition ... Act, legislation that grants the U.S. Food and Drug Administration ...
... , , , ... Administration announced today a ban on cigarettes with flavors characterizing fruit, ... Smoking Prevention and Tobacco Control Act, is part of a national ... the leading preventable cause of death in America. , , ...
... NEW YORK, Sept. 22 FiLife ( www.FiLife.com ... that public concerns about costs dominated its "Fix Healthcare in Three ... President Obama continues to push for healthcare reform, highlighted by his ... between Dow Jones & Company and IAC (Nasdaq: IACI ...
... , , , NEW ... research report is available in its catalogue. , , ... Players, and Critical Trends in a Fast-Changing Industry ... , The global market for human vaccines has ...
Cached Medicine News:Health News:Reportlinker Adds Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition Report 2Health News:Reportlinker Adds Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition Report 3Health News:Reportlinker Adds Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition Report 4Health News:Reportlinker Adds Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition Report 5Health News:Reportlinker Adds Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition Report 6Health News:Reportlinker Adds Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition Report 7Health News:Reportlinker Adds Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition Report 8Health News:Reportlinker Adds Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition Report 9Health News:FaxSIPit and FaxBack Announce Partnership To Bring Reliable VoIP Fax to Service Providers 2Health News:FaxSIPit and FaxBack Announce Partnership To Bring Reliable VoIP Fax to Service Providers 3Health News:Flavored Cigarette Ban Takes Effect 2Health News:Flavored Cigarette Ban Takes Effect 3Health News:Candy and Fruit Flavored Cigarettes Now Illegal in United States; Step is First Under New Tobacco Law 2Health News:FiLife's 'Fix Healthcare in Three Words' Twitter Contest Reveals Money is the Key Issue 2Health News:Reportlinker Adds Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Report 2Health News:Reportlinker Adds Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Report 3Health News:Reportlinker Adds Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Report 4Health News:Reportlinker Adds Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Report 5Health News:Reportlinker Adds Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Report 6Health News:Reportlinker Adds Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Report 7Health News:Reportlinker Adds Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Report 8Health News:Reportlinker Adds Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Report 9Health News:Reportlinker Adds Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Report 10Health News:Reportlinker Adds Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Report 11Health News:Reportlinker Adds Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Report 12
... unique microprocessor controlled shaking incubator that accommodates ... or 384 well format. Speed, temperature and ... and all are displayed on the LCD. ... protective cover. The Millennium 2000 can be ...
Modular flow cytometer with all options....
This unique system combines the analytical power of a research cytometer into a compact, truly walk away, clinical analyzer ergonomically designed to expedite sample throughput....
... The IMMULITE 2000, a continuous random ... of 200 tests per hour, has ... and consolidation in medium- and high-volume ... with its self-explanatory graphical user interface, ...
Medicine Products: